Literature DB >> 18281379

Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists.

Gary P Van Guilder1, Brian L Stauffer, Jared J Greiner, Christopher A Desouza.   

Abstract

Muscarinic receptor agonists have primarily been used to characterize endothelium-dependent vasodilator dysfunction with overweight/obesity. Reliance on a single class of agonist, however, yields limited, and potentially misleading, information regarding endothelial vasodilator capacity. The aims of this study were to determine 1) whether the overweight/obesity-related reduction in endothelium-dependent vasodilation extends beyond muscarinic receptor agonists and 2) whether the contribution of nitric oxide (NO) to endothelium-dependent vasodilation is reduced in overweight/obese adults. Eighty-six middle-aged and older adults were studied: 42 normal-weight (54 +/- 1 yr, 21 men and 21 women, body mass index = 23.4 +/- 0.3 kg/m(2)) and 44 overweight/obese (54 +/- 1 yr, 28 men and 16 women, body mass index = 30.3 +/- 0.6 kg/m(2)) subjects. Forearm blood flow (FBF) responses to intra-arterial infusions of acetylcholine in the absence and presence of the endothelial NO synthase inhibitor N(G)-monomethyl-l-arginine, methacholine, bradykinin, substance P, isoproterenol, and sodium nitroprusside were measured by strain-gauge plethysmography. FBF responses to each endothelial agonist were significantly blunted in the overweight/obese adults. Total FBF (area under the curve) to acetylcholine (50 +/- 5 vs. 79 +/- 4 ml/100 ml tissue), methacholine (55 +/- 4 vs. 86 +/- 5 ml/100 ml tissue), bradykinin (62 +/- 5 vs. 85 +/- 4 ml/100 ml tissue), substance P (37 +/- 4 vs. 57 +/- 5 ml/100 ml tissue), and isoproterenol (62 +/- 4 vs. 82 +/- 6 ml/100 ml tissue) were 30%-40% lower in the overweight/obese than normal-weight adults. N(G)-monomethyl-l-arginine significantly reduced the FBF response to acetylcholine to the same extent in both groups. There were no differences between the groups in the FBF responses to sodium nitroprusside. These results indicate that agonist-stimulated endothelium-dependent vasodilation is universally impaired with overweight/obesity. Moreover, this impairment appears to be independent of NO.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281379      PMCID: PMC3686114          DOI: 10.1152/ajpheart.01281.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  33 in total

1.  Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men.

Authors:  C A DeSouza; L F Shapiro; C M Clevenger; F A Dinenno; K D Monahan; H Tanaka; D R Seals
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

2.  Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress.

Authors:  Annemarie E Silver; Stacy D Beske; Demetra D Christou; Anthony J Donato; Kerrie L Moreau; Iratxe Eskurza; Phillip E Gates; Douglas R Seals
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

3.  Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.

Authors:  D E Newby; R A Wright; C Labinjoh; C A Ludlam; K A Fox; N A Boon; D J Webb
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

4.  Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults.

Authors:  Gary P Van Guilder; Greta L Hoetzer; Jared J Greiner; Brian L Stauffer; Christopher A Desouza
Journal:  Obesity (Silver Spring)       Date:  2006-12       Impact factor: 5.002

Review 5.  Endothelin in cardiovascular control: the role of endothelin antagonists.

Authors:  R R Wenzel; P Czyborra; T Lüscher; T Philipp
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

6.  Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C.

Authors:  F Perticone; R Ceravolo; M Candigliota; G Ventura; S Iacopino; F Sinopoli; P L Mattioli
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

7.  Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries.

Authors:  J Al Suwaidi; S T Higano; D R Holmes; R Lennon; A Lerman
Journal:  J Am Coll Cardiol       Date:  2001-05       Impact factor: 24.094

Review 8.  Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD.

Authors:  Atul Singhal
Journal:  Proc Nutr Soc       Date:  2005-02       Impact factor: 6.297

9.  Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.

Authors:  William I Sivitz; Sheila M Wayson; Margaret L Bayless; Christine A Sinkey; William G Haynes
Journal:  J Diabetes Complications       Date:  2007 May-Jun       Impact factor: 2.852

10.  Impaired endothelium-dependent vasodilation in normotensive and normoglycemic obese adult humans.

Authors:  Gary P Van Guilder; Greta L Hoetzer; Donald R Dengel; Brian L Stauffer; Christopher A DeSouza
Journal:  J Cardiovasc Pharmacol       Date:  2006-02       Impact factor: 3.105

View more
  16 in total

1.  Metabolic syndrome and endothelin-1 mediated vasoconstrictor tone in overweight/obese adults.

Authors:  Natalia G Rocha; Danielle L Templeton; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Metabolism       Date:  2014-04-18       Impact factor: 8.694

2.  Enhanced endothelin-1 system activity with overweight and obesity.

Authors:  Brian R Weil; Christian M Westby; Gary P Van Guilder; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

3.  CD31+ T cells, endothelial function and cardiovascular risk.

Authors:  Brian R Weil; Erich J Kushner; Kyle J Diehl; Jared J Greiner; Brian L Stauffer; Christopher A Desouza
Journal:  Heart Lung Circ       Date:  2011-07-20       Impact factor: 2.975

4.  Antiobesogenic role of endothelial nitric oxide synthase.

Authors:  Brian E Sansbury; Bradford G Hill
Journal:  Vitam Horm       Date:  2014       Impact factor: 3.421

5.  Obesity and overweight associated with increased carotid diameter and decreased arterial function in young otherwise healthy men.

Authors:  Rebecca M Kappus; Christopher A Fahs; Denise Smith; Gavin P Horn; Stomatis Agiovlasitis; Lindy Rossow; Sae Y Jae; Kevin S Heffernan; Bo Fernhall
Journal:  Am J Hypertens       Date:  2013-09-18       Impact factor: 2.689

6.  Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.

Authors:  Andreas M Beyer; Deng-Fu Guo; Kamal Rahmouni
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

7.  Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.

Authors:  Mias Pretorius; Nancy J Brown
Journal:  J Pharmacol Exp Ther       Date:  2009-10-19       Impact factor: 4.030

Review 8.  Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle.

Authors:  Michael G Clark
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

Review 9.  Regulation of obesity and insulin resistance by nitric oxide.

Authors:  Brian E Sansbury; Bradford G Hill
Journal:  Free Radic Biol Med       Date:  2014-05-28       Impact factor: 7.376

10.  Microvascular function in younger adults with obesity and metabolic syndrome: role of oxidative stress.

Authors:  Jacqueline K Limberg; John W Harrell; Rebecca E Johansson; Marlowe W Eldridge; Lester T Proctor; Joshua J Sebranek; William G Schrage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-09       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.